limited industry biotechnology founded 2000 headquarters ahmedabad india products neukine gcsf erykine epo intalfa ifn pegasta peg gcsf terifrac teriparatide mabtas rituximab folisurge fsh number of employees 300 350 2013 website http www.intaspharma.com the biologics business unit bu of intas pharmaceuticals limited was formerly an independent biotechnology company and was known as intas biopharmaceuticals ltd. intas pharmaceuticals limited is an indian company headquartered in ahmedabad india . the biologics bu is located in moraiya ahmedabad and is one of the leading biosimilar product manufacturers in asia . the biologics bu of intas pharmaceuticals has biopharmaceutical operations with r & d facility and an eu gmp certified bio pharmaceutical manufacturing facility . 1 contents 1 history 2 products 3 collaborations & partnerships 4 european union approval 5 references 6 external links 7 news articles history edit intas biopharmaceuticals limited was set up in year 2000 as an independent biotechnology division of intas pharmaceuticals ltd. a mid sized generic formulation manufacturer located in ahmedabad india . the bu was merged with the parent company intas pharmaceuticals limited in the year 2013 . corporate headquarters and production site of intas biopharmaceuticals ltd. the company faced eu gmp good manufacturing practice audit in december 2006 to seek approval of clinical trial of its biosimilar filgrastim in europe and was certified as eu gmp compliant in april 2007 becoming the first company in india to receive such certification for biologics facility . apart from eu gmp certification the company also has approvals from mcc south africa gulf cooperation council gcc syria yemen belarus and several other national health authorities for its manufacturing facility and products . products edit intas biosimilar development timeline intas biologics has an extensive product portfolio of biosimilars across microbial and mammalian cell culture . its products include neukine gcsf erykine epo intalfa ifn pegasta peg gcsf terifrac teriparatide mabtas rituximab folisurge fsh . it is india s first biosimilars manufacturing unit to receive european union good manufacturing practice eu gmp certification for the drug substance microbial and drug product manufacturing facilities attesting to highest quality of manufacturing and quality systems . in addition to the eu gmp intas biological bu facilities are approved by various other regulatory agencies such as anvisa gcc mcc indonesia etc. mabtas is rituximab biosimilar of intas intas manufactured filgrastim registered in eu collaborations & partnerships edit intas has several strategic marketing alliances and out licensing collaborations with many international companies across both regulated and emerging pharmaceutical markets such as europe china s e asia middle east russia & cis south & central america and africa . intas biosimilar are registered in more than 22 countries and under registration in more than 25 countries through strategic marketing alliances . three of intas biosimilar assets are already partnered for the eu us canada china and other markets . the first product for the regulated markets will be gcsf and has received eu registration . several other biosimilar programs are at advance stage of development and available for partnering discussions . intas signed an agreement with canadian drug major apotex inc in may 2008 to co develop and market the low cost version of a biotech cancer medicine filgrastim g csf in north america and europe . 2 intas developed and manufactured filgrastim gcsf became the first biosimilar manufactured by an indian company to be registered in eu . apotex and intas in jan 2009 extended their agreement to develop a biosimilar version of pegfilgrastim . this collaboration gives apotex the rights to market the product manufactured by intas biopharmaceuticals in north america europe and selected other countries . 3 european union approval edit accord healthcare the international arm of intas pharmaceuticals ltd has received marketing authorization for its filgrastim brand name accofil valid throughout the european union . the product is manufactured by intas in its ema certified plant in india . 4 accofil has already won two tenders in netherlands and the uk . the product is one of the many biosimilars that intas will be launching in the european union usa and other regulated markets . 5 references edit intas mfg unit gets eu gmp certification . the economic times . 13 june 2007 . intas apotex to develop cancer drug . business standard . may 2008 . apotex and intas biopharmaceuticals extend their collaborative development of biosimilars to include peg filgrastim . press release intas biopharmaceuticals . jan 2009 . intas pharmaceuticals limited gets the 1st biosimilar approval for eu . press release intas pharmaceuticals . jun 2014 . intas pharma launches its first biosimilar product accofil in europe . economic times . feb 2015 . external links edit intas pharmaceuticals ltd. v t e major indian companies economy of india list of companies of india automotive ashok leyland bajaj auto eicher motors hero motocorp hindustan motors mahindra & mahindra tafe tata motors tvs aerospace and defence bharat electronics drdo hal ordnance factories conglomerates aditya birla adani avantha bajaj bharti essar essel gmr godrej gvk hinduja itc jaypee jindal kirloskar jsw l & t lanco mahindra muthoot murugappa ramoji reliance adag reliance rpg sahara shapoorji pallonji sun tata tvs torrent ub videocon wadia civil aviation air india indigo jet airways consumer goods and retail britannia industries dabur flipkart future group godrej consumer hindustan unilever itc nirma reliance retail tata global beverages energy and natural resources bharat petroleum cairn india chennai petroleum coal india gail essar oil hindustan petroleum indian oil corporation l & t national aluminum nhpc nmdc nlc ntpc oil india ongc power finance power grid rinl reliance infrastructure recl sci sesa goa suzlon energy tata power finance andhra bank axis bank bank of baroda bank of india canara bank central bank of india hdfc bank icici bank idbi bank ing vysya bank jammu & kashmir bank kotak mahindra bank lic mudra bank muthoot finance ltd punjab national bank sbi tamilnad mercantile bank union bank of india yes bank healthcare pharmaceutical & biotech aurobindo pharma cadila healthcare cipla glenmark pharmaceuticals dr. reddy s idpl iil lupin sun pharmaceutical manufacturing and heavy industries acc ambuja apollo tyres bengal chemicals and pharmaceuticals bhushan bhel dlf gammon india havells hcc hindalco india cements jindal steel jsw mrf sail tata steel ultratech information technology hcl technologies infosys tata consultancy services tech mahindra wipro media sun group the times group living media telecommunications aircel airtel bsnl idea cellular micromax mobile mtnl reliance communications tata communications benchmark fy 2015 16 revenues of over us 1 billion news articles edit 1 intas biopharma to market pemetrexed in india february 2009 2 apotex and intas biopharmaceuticals extend their collaborative development of biosimilars to include peg filgrastim january 2009 3 intas biopharma to market lung cancer drug gefitinib in india may 2008 4 biosimilar g csf cooperation on three continents april 2008 5 paragon of success june 2008 6 intas biopharma launches new sales divisions in india march 2008 7 intas pharmaceuticals limited gets the 1st biosimilar approval for eu june 2014 8 intas pharma launches its first biosimilar product in europe feb 2015 9 ahmedabad based intas pharma launches biosimilar in eu feb 2015 10 intas pharmaceuticals becomes the first indian company to launch a biosimilar in the eu feb 2015 11 intas pharmaceuticals launches biosimilar in europe feb 2015 retrieved from https en.wikipedia.org w index.php title intas biopharmaceuticals & oldid 660443144 categories pharmaceutical companies of indiabiotechnology companies of indiapharmaceutical companies established in 2000companies based in ahmedabad navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages add links this page was last modified on 2 may 2015 at 15 34 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view